Information Provided By:
Fly News Breaks for August 2, 2016
UNH, CVS
Aug 2, 2016 | 13:48 EDT
Jefferies analyst Mark Wiltamuth noted that CVS (CVS) reported better than expected adjusted earnings and that its first comment on the 2017 PBM selling season showed strong net wins of $4.6B, which was above his expectation for $3B-$4B in net new PBM wins. After 3 high visibility PBM losses to OptumRx (UNH) in May and early June, the price discipline, strong wins and retention figures should elicit a relief rally, said Wiltamuth, who has a Buy rating and $122 price target on CVS shares.
News For CVS;UNH From the Last 2 Days
UNH
Apr 19, 2024 | 04:50 EDT
Deutsche Bank analyst George Hill raised the firm's price target on UnitedHealth to $562 from $545 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat with many moving pieces caused by the cyberattack on Change Healthcare, which left earnings quality and guidance up to investor interpretation, the analyst tells investors in a research note. The firm sees the full impact of the hack, as well as conservatism around cost trend and utilization would impact UnitedHealth earnings by only 2% for the full year.
UNH
Apr 18, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Genuine Parts (GPC) $159.09 +15.03, Globe Life (GL) $66.97 +3.74, Anthem (ELV) $532.10 +23.13, United Continental (UAL) $50.59 +1.84, and UnitedHealth (UNH) $494.80 +15.81.
UNH
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
UNH
Apr 17, 2024 | 08:11 EDT
RBC Capital analyst Ben Hendrix lowered the firm's price target on UnitedHealth to $555 from $596 but keeps an Outperform rating on the shares. The company reported a "better than feared" Q1, but the debate over utilization trends is expected to persist through the first half as excess reserves skew the medical care ratio picture, the analyst tells investors in a research note. RBC also notes that its added caution reflects UnitedHealth's "reduced claims visibility".